Denmark· DK-28104456009
Norvir
A ritonavir product containing ritonavir, registered in Denmark by AbbVie Deutschland GmbH & Co. KG. The same ATC class is registered in 16 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Ritonavir is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AE03 (ritonavir), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Ritonavir · ATC J05AE03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ritonavir costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), the median price runs from $4.15 in France to $20.09 in Switzerland — a ×4.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ritonavir · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$20.09
- FR France$4.15
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- RITONAVIR
- Manufacturer
- AbbVie Deutschland GmbH & Co. KG
- Country
- Denmark (DK)
- ATC code
- J05AE03
- ATC class
- Ritonavir
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104456009
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
515 interactions on record for ritonavir.
Graded by severity as the source publishes them — 149 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ritonavir · interactions on record
515 records
- 149 severe
- 238 moderate
- 19 minor
- 66 info
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
- EluxadolineA07DA06severe
43 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J05AE03
Ritonavir, as other registers publish it.
- CanadaAURO-RITONAVIRAURO PHARMA INC
- IrelandKaletraAbbVie Deutschland GmbH & Co. KG
- IrelandKaletra (80 mg + 20 mg)/ml oral solutionAbbVie Deutschland GmbH & Co. KG
- IrelandLopinavir/Ritonavir Viatris 100 mg/25 mg film-coated tabletsViatris Limited
- FinlandNorvirAbbVie Deutschland GmbH&Co.KG
- FinlandNorvirAbbott Laboratories Ltd.
- PolandNorvirAbbVie Deutschland GmbH & Co. KG
- FinlandNorvirAbbVie Deutschland GmbH&Co.KG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac552b5d-1e1b-4ffc-a082-cb2e665aefda GET /v1/drugs/ac552b5d-1e1b-4ffc-a082-cb2e665aefda?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "100 mg",
"auth_role": "MOD",
"dk_drugid": "28104456009",
"substance": "RITONAVIR",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "40203"
}See everything about ritonavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.